Literature DB >> 21855912

Effects of ovariectomy and estrogen replacement on the urethral continence reflex during sneezing in rats.

Takeya Kitta1, Donna J Haworth-Ward, Minoru Miyazato, Masashi Honda, William C de Groat, Katsuya Nonomura, David A Vorp, Naoki Yoshimura.   

Abstract

PURPOSE: Stress urinary incontinence is often seen in postmenopausal women but limited information is available on hormone dependent changes of urethral function. Thus, we examined how ovariectomy and estrogen replacement affect urethral continence mechanisms.
MATERIALS AND METHODS: In female nulliparous Sprague-Dawley® rats under urethane anesthesia after ovariectomy with or without estrogen replacement we measured urethral response amplitude during sneezing, urethral baseline pressure and sneeze induced leak point pressure. Whole urethras were tested for ex vivo urethral properties.
RESULTS: Urethral response amplitude during sneezing was significantly decreased in 3 and 6-week ovariectomized rats. Urethral baseline pressure was significantly decreased only in 6-week ovariectomized rats. After estrogen replacement urethral baseline pressure but not urethral response amplitude during sneezing was significantly increased. Neither 3-week ovariectomized nor sham operated rats leaked during sneezing but fluid leakage was observed in 63% of 6-week ovariectomized rats. Estrogen replacement decreased the stress urinary incontinence incidence to 25%. Ex vivo testing revealed a significant increase in middle urethral compliance and a decrease in β stiffness at the proximal and middle urethras in 6-week ovariectomized rats.
CONCLUSIONS: Results indicate that ovariectomy significantly impairs urethral function from the early stage (3 weeks) but does not induce stress urinary incontinence until the late stage (6 weeks). Also, estrogen replacement restores only the urethral baseline pressure parameter, leading to partial prevention of stress urinary incontinence. Since urethral baseline pressure and urethral response amplitude during sneezing parameters are related to urethral smooth and striated muscle activity, respectively, based on our previous studies, hormone replacement therapy may be partially effective for stress urinary incontinence by enhancing smooth muscle mediated urethral activity under stress conditions such as sneezing.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21855912     DOI: 10.1016/j.juro.2011.05.045

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Effects of a selective androgen receptor modulator (SARM), GSK2849466A, on stress urinary incontinence and bladder activity in rats with ovariectomy-induced oestrogen deficiency.

Authors:  Katsumi Kadekawa; Naoki Kawamorita; Takahiro Shimizu; Masahiro Kurobe; Philip S Turnbull; Sundeep Chandra; Takahito Kambara; Joanna C Barton; Alan J Russell; Naoki Yoshimura
Journal:  BJU Int       Date:  2020-03-20       Impact factor: 5.588

2.  Stress urinary incontinence and the forgotten female hormones.

Authors:  Nicholas Siddle; Eboo Versi
Journal:  Int Urogynecol J       Date:  2022-04-23       Impact factor: 1.932

3.  [Overactive bladder in the elderly].

Authors:  T Bschleipfer; F M Wagenlehner; G Lüdecke; A Pilatz; W Weidner
Journal:  Urologe A       Date:  2013-06       Impact factor: 0.639

4.  The mysteries of menopause and urogynecologic health: clinical and scientific gaps.

Authors:  Marianna Alperin; Lindsey Burnett; Emily Lukacz; Linda Brubaker
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

5.  Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence.

Authors:  Yasutaka Murata; Daisuke Obinata; Taro Matsumoto; Yuichiro Ikado; Koichiro Kano; Noboru Fukuda; Kenya Yamaguchi; Satoru Takahashi
Journal:  Int Urol Nephrol       Date:  2022-02-17       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.